Competition is heating up in the weight-loss medication market, as Novo Nordisk and Eli Lilly face a growing number of challengers. One such newcomer is Hims & Hers, an American e-pharmacy that has entered the fray with its own version of Wegovy, a popular slimming drug.
In May, Hims & Hers replicated Wegovy due to a quirk in American law allowing pharmacies to manufacture brand-name drugs during shortages. This move could potentially disrupt the market and give customers more affordable options. Analysts expect Hims & Hers to earn around $145m from its weight-loss medication this year.
Source: https://www.livemint.com/industry/competition-will-make-weight-loss-drugs-better-cheaper-and-bigger-11735020926608.html